Virtue Diagnostics Funding: $100M Raised, Series B (2022)
Virtue Diagnostics has raised $100M in total funding. Latest round: Series B. Backed by Sequoia China, Morningside Ventures, ORIZA Holdings.
Virtue Diagnostics funding overview
Virtue Diagnostics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for Virtue Diagnostics runs through 2022; nothing later has been disclosed. Investors on record include Sequoia China, Morningside Ventures, ORIZA Holdings, Lilly Asia Ventures, PerkinElmer Ventures. 5 distinct backers are named across the disclosed rounds.
Virtue Diagnostics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Virtue Diagnostics?
Sequoia China, Morningside Ventures, ORIZA Holdings, Lilly Asia Ventures, PerkinElmer Ventures are named among the investors backing Virtue Diagnostics.
What was the latest Virtue Diagnostics funding round?
The most recent disclosed round is a Series B, announced in January 2022.
Where is Virtue Diagnostics based?
No headquarters location is disclosed for Virtue Diagnostics.
When did Virtue Diagnostics last raise?
The last disclosed Virtue Diagnostics round closed in January 2022 at Series B.
Totals shown for Virtue Diagnostics aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
